Observations on the Initial Implementation of the Medicare Prescription Drug Program: Perspectives of State Medicaid Directors Through a Focus Group Discussion

Medicaid/CHIP

>	Main Page
>	Children
>	Enrollment and Outreach
>	Long-Term Care
>	Low-Income Families
>	Managed Care
>	Medicare/Medicaid Dual Enrollees
>	People with Disabilities
>	Prescription Drugs
>	Spending & Budgets
>	Waivers

U.S. Global Health Policy

Minority Health

Women's Health Policy

Media and Health

Pulling It Together, From Drew Altman

Kaiser Commission on Medicaid and the Uninsured

Kaiser Polls

Media Fellowships

Barbara Jordan Health Policy Scholars Program

News Media Partnerships

Entertainment Media Partnerships

South Africa

Fast Facts

Observations on the Initial Implementation of the Medicare Prescription Drug Program: Perspectives of State Medicaid Directors Through a Focus Group Discussion

Medicaid directors express the need to continue to focus on the interaction between Medicaid and the Medicare prescription drug benefit and to address the key system and coordination issues that remain, particularly with the potential disruptions that could occur in January 2007 when new Medicare drug plan contracts and recalculated benchmarks for the low-income subsidy take effect.

Report (.pdf)

Information provided by the Kaiser Commission on Medicaid and the Uninsured
Publication Number: 7520
Publish Date: 2006-05-18